Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-06-21
2005-06-21
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S043000, C536S028500, C536S028510
Reexamination Certificate
active
06908906
ABSTRACT:
The present invention provides crystalline forms and compositions thereof, of a pyrimidine nucleoside derivative of formula (I) having anti-tumour activity, wherein formula (I) is:
REFERENCES:
patent: 5691319 (1997-11-01), Kaneko et al.
patent: 0 536 936 (1993-04-01), None
patent: 05-194497 (1993-08-01), None
patent: 2569251 (1996-10-01), None
English translation of International Preliminary Examination Report Form PCT/IPEA/409 in International Application No. PCT/JP02/00986.
Harashima Susumu
Numagami Eiji
Ohtsuka Keiichi
Takita Takashi
Frishauf Holtz Goodman & Chick P.C.
Henry Michael C.
Sankyo Company Limited
Wilson James O.
LandOfFree
Crystalline forms of pyrimidine nucleoside derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of pyrimidine nucleoside derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of pyrimidine nucleoside derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3482791